Read + Share
Staller K, Clukey J, Madva EN, Healy BC, et al. CYP2D6 Metabolizer Status Does Not Predict Response or Tolerability of Low-Dose
Nortriptyline for Irritable Bowel Syndrome With Diarrhea. Gastro Hep Adv 2026;5:101111.
PMID: 42831162
|
 |
|
Staller K, Clukey J, Madva EN, Healy BC, et al. CYP2D6 Metabolizer Status Does Not Predict Response or Tolerability of Low-Dose
Nortriptyline for Irritable Bowel Syndrome With Diarrhea. Gastro Hep Adv 2026;5:101111.
PMID: 42831162
|
|
|
|